Inhibitory effect of 18β-glycyrrhetinic acid on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in mice

被引:44
作者
Agarwal, MK [1 ]
Iqbal, M [1 ]
Athar, M [1 ]
机构
[1] Hamdard Univ, Dept Med Elementol & Toxicol, Fac Sci, New Delhi 110062, India
关键词
glycyrrhetinic acid; cutaneous oxidative stress; tumor promotion;
D O I
10.1179/135100005X57346
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Glycyrrhetinic acid is an aglycone of glycyrrhizic acid, another major active component of licorice roots. Licorice root extract has been used for a long time as a medicine and a natural sweetening additive. In the present study, we found that glycyrrhetinic acid inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA) mediated oxidative stress and tumor promotion in murine skin. Topical application of TPA alone in mouse skin enhances ornithine decarboxylase activity and also increases [H-3]thymidine incorporation in DNA. Topical application of TPA also resulted in the depletion of glutathione, activities of glutathione metabolizing and antioxidant enzymes. Application of glycyrrhetinic acid prior to TPA treatment reduces this enhanced ODC activity, [H-3]-thymidine incorporation in DNA and oxidative stress. Glycyrrhetinic acid was also found to inhibit DMBA/TPA-induced skin tumor formation at doses of 1.25 and 2.5 mg by reducing the number of tumors per mouse by 24% ( P < 0.05) and 62% ( P < 0.05), respectively. These results suggest that glycyrrhetinic acid, an antioxidant, is a potential chemopreventive agent that can inhibit DMBA/TPA-induced cutaneous oxidative stress and tumor promotion.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 37 条
[1]
AGARWAL R, 1991, PHARM SKIN, P371
[2]
Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO
[3]
2-B
[4]
AFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS [J].
ARMANINI, D ;
KARBOWIAK, I ;
FUNDER, JW .
CLINICAL ENDOCRINOLOGY, 1983, 19 (05) :609-612
[5]
BLUMBERG PM, 1988, CANCER RES, V48, P1
[6]
BOUTWELL RK, 1982, ADV POLYAMINE RES, V4, P127
[7]
Caliborne A, 1985, CRC HDB METHODS OXYG, P283
[8]
CARLBERG I, 1975, J BIOL CHEM, V250, P5475
[9]
DIGIOVANNI J, 1991, PROG EXP TUMOR RES, V33, P192
[10]
FUJISAWA K, 1980, Asian Medical Journal, V23, P745